Get the content you want anytime you want.
REGISTER NOW | SIGN IN
2019 TCT | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR

Select coverage from 2019 TCT | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR is included below:

Valganciclovir Preferred to Prevent Cytomegalovirus After Allogeneic Hematopoietic Cell Transplantation
Investigators at Memorial Sloan Kettering Cancer Center determined valganciclovir was the preferred first-line preemptive therapy to prevent cytomegalovirus in patients following an allogeneic hematopoietic cell transplantation.
The Longer the Scrub, the Cleaner the Hub
The length of mechanical friction applied to the needleless connector of a central venous catheter before insertion may make a difference in rate of disinfection.
No Active TB Detected in HSCT Patients in Mexico, Study Finds
A study conducted at the Salvador Zubirán National Institute of Health Sciences and Nutrition found that there were no cases of active tuberculosis detected in HSCT patients.
No Relevant Pharmacokinetic Interactions Between Rezafungin and Commonly Co-administered Drugs
Investigators detected no relevant change in systemic concentrations of 9 probe drugs when rezafungin was dosed concomitantly.
FEATURED
Big advances in treatment can't make up for an inability to stop new infections, which number 5,000 per day worldwide.